Ledger.Open graph →

SEC Form D · Amendment · filed May 2, 2016

Renibus Therapeutics, Inc

Offering

$12.5M

Sold

$10.9M

Exemption

Rule 506(b)

Industry

Pharmaceuticals

Location

LANTANA, TX

Type

—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (18)

Jennifer D. Rasmussen · Lantana, TXDirector Dale Jones · Lantana, TXDirector Harpreet Kaur · Lantana, TXExec · Director Carlos Guillem · Lantana, TXExec · Director Jocelyn D. Keyser · Lantana, TXDirector Nels D. Bergmark · Lantana, TXExec Arthur B. Mcwood · Troy, MIDirector Jason L. Yoffy · Troy, MIExec · Director Gregory Dinardo · Austin, TXExec Larry L. Adloff · Troy, MIExec · Director Timothy L. Hoel · Troy, MIDirector Alexander Bullington · Forest Hill, MDDirector John B. Coppolino · Troy, MIExec Lawrence B. Carlson · Troy, MIDirector Daniel J. Jenuwine · Troy, MIExec · Director Jim M. Hodge · Henderson, NVExec · Director Randon M. Hansen · Henderson, NVDirector Mark M. Stoker · Henderson, NVDirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗